Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Robert D. Ferrera, MD
EIR
•Robert D. Ferrera, MD•May 22, 2008

Robert D. Ferrera, MD – FDA EIR, May 22, 2008

Record Details

An FDA inspection of Ferrera, R. David, MD, operating as Sacramento Medical Research Group, was conducted from May 8 to May 22, 2008. This high-priority inspection, performed under Compliance Program 7348.811 for Clinical Investigators, aimed to validate clinical investigator data for a pre-approval New Drug Application. The inspection identified critical deviations from regulatory requirements and the signed investigator agreement.

The main violations, documented on an FDA Form 483, included the improper dispensing of study medication where an incorrect drug kit (active drug instead of placebo) was issued to a subject, and the failure to report an adverse event (healing vesicular lesions) for another subject on the official Case Report Form. These issues represent a direct violation of 21 CFR 312.60.

Further observations revealed numerous recordkeeping deficiencies, such as inconsistent dating, blank data fields, uninitialed corrections, and inaccurate data transcription between source documents and CRFs. There was also inadequate documentation for protocol deviations, including the use of rescue medication or the inclusion of a subject with an undisclosed medical history. Additionally, different versions of informed consent forms were used concurrently, and the company's website contained inaccurate claims regarding prior FDA audits.

Management, represented by the Research Coordinator, acknowledged the findings and committed to improved diligence in medication dispensing, enhanced adverse event reporting procedures, and better record management practices. A written response to the inspectional findings was promised, necessitating a comprehensive review and overhaul of their clinical trial conduct and documentation processes to ensure full compliance.

Company
Robert D. Ferrera, MD
Inspection date
May 22, 2008
Product type
drugs
Office
San Francisco District Office
Person
  • Stuart W. Russell
View Company Profile

ID · 30115841-790b-4834-a8cd-6d8a6181442d

Violation Codes2
21 CFR 312.6021 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for Robert D. Ferrera, MD
  • 483 - 2008-05-22May 22, 2008

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Robert D. Ferrera, MD
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.